Conceptus (CPTS) Cuts FY11 Sales Guidance Below the Street
Tweet
Share
E-mailGet Alerts CPTS Hot Sheet
Price: $31.02 --0%
Financial Fact:
Research and development: 2.78M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 2.78M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Conceptus (Nasdaq: CPTS) cuts its FY11 sales from $132-$136 million to $126-$128 million, which compares to the Street estimate of $132.13 million. Sees adj-EBITDA lower than the guidance range given on Oct. 25th.
The company has terminated its credit line and may consider alternatives to refinance some notes.
The company has terminated its credit line and may consider alternatives to refinance some notes.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Ocean Power Technologies revises fiscal 2026 results after audit
- Robo.ai completes acquisitions, plans interim report for Aug. 24
Create E-mail Alert Related Categories
GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
